Flerie writes down Empros Pharma stake, stock falls

Swedish pharma investor Flerie has written down the value of its holding in portfolio company Empros Pharma, citing a lack of economic conditions. The writedown triggered a decline in Flerie's share price. This is a company-specific valuation adjustment, not a systemic market signal.